Pearl River Capital, LLC Insmed Inc Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$16.98 - $23.15 $144,771 - $197,376	-8,526 Reduced 36.94%	14,552 $290,000
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $38,106 - $51,483	-1,825 Reduced 7.33%	23,078 $497,000
Q2 2022 Aug 12, 2022	BUY	$17.07 - $25.71 $425,094 - $640,256	24,903 New	24,903 $491,000
Q3 2021 Nov 12, 2021	SELL	$22.46 - $29.47 $212,157 - $278,373	-9,446 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$24.17 - $36.01 $228,309 - $340,150	9,446 New	9,446 $269,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.